Windlas Biotech Share Price History and Returns 2021 to 2026
|
Windlas Biotech Limited |
|||
|
Price: ₹819.20 (-0.62%) | ||
| 52 Week Low: ₹697.40 52 Week High: ₹1,097.90 |
|||
| Market Capital: 1,815.24 Crore (Small-cap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Windlas Biotech Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Windlas Biotech Recent Performance
- 3: Windlas Biotech Stock Price Chart From 2021 to 2026
- 4: Windlas Biotech Stock Price History Table From 2021 to 2026
- 5: Analyzing the Impact of Investing in Windlas Biotech
- 5.1: Windlas Biotech Stock Returns In Last 5 Years
- 6: Windlas Biotech Returns vs Bank FD Returns
Windlas Biotech Stock Highlights
As of 15 Jun 2026, Windlas Biotech Stock price is ₹819.20 which is ₹278.70 below 52-week high of ₹1,097.90 and ₹121.80 above 52-week low of ₹697.40
52-Week High Low
- Windlas Biotech 52-Week High is ₹1,097.90 occurred on 19 Aug 2025
- Windlas Biotech 52-Week Low is ₹697.40 occurred on 16 Mar 2026
All Time High
- The all-time high or the highest price that Windlas Biotech stocks have ever touched was ₹1,198.25 and this occurred on 06 Nov 2024.
- The highest closing price at which Windlas Biotech stocks have ever closed was ₹1,144.25 recorded on 06 Dec 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Windlas Biotech Recent Performance
Over the past 15 trading days, the value of Windlas Biotech's stock has increased by ₹33.95 (+4.32%). On 25 May 2026, its one share was worth ₹785.25 and by 15 Jun 2026, the value jumped to ₹819.2. During this period it created a highest high of ₹852.55 and lowest low of ₹770.15.
Click on legend items to show/hide respective price lines
Windlas Biotech Stock Price Chart From 2021 to 2026
Click on legend items to show/hide respective price lines
Windlas Biotech Stock Price History Table From 2021 to 2026
| Year | Windlas Biotech | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2026 | ₹824.30 | 3.6% |
↑ ₹950.00 ↓ ₹697.00 |
| 2025 | ₹795.05 | -23.7% |
↑ ₹1,140.00 ↓ ₹665.00 |
| 2024 | ₹1,041.15 | 142.8% |
↑ ₹1,198.00 ↓ ₹431.00 |
| 2023 | ₹428.75 | 71.4% |
↑ ₹466.00 ↓ ₹220.00 |
| 2022 | ₹250.10 | -9.4% |
↑ ₹292.00 ↓ ₹203.00 |
| 2021 | ₹275.95 | - |
↑ ₹452.00 ↓ ₹258.00 |
Analyzing the Impact of Investing in Windlas Biotech
Windlas Biotech Stock price in the year 2021 was ₹275.95. If you had invested ₹10,000 in Windlas Biotech Stock in 2021, in 5 years, your investment would have grown to ₹29,871 by the end of 2026. This represents a positive return of 198% from 2021 to 2026, with a compound annual growth rate (CAGR) of 24.4%.
Windlas Biotech Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹1,198.25 and lowest was: ₹203.25
- Windlas Biotech Stock price in 2021 was ₹275.95
- By 2026, its stock price rose to ₹824.30
- It gave a positive return of over 198.7% with a CAGR of 24.5% over the last 5 years
- If you had invested ₹10,000 in Windlas Biotech in 2021 then in 5 years, your investment would have grown to ₹29,871.35 by 2026, which is 2.99 times of your initial investment.
Windlas Biotech Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Windlas Biotech Shares | ₹10,000 | ₹29,871.35 | 198.7% |
| Bank FD (Simple Interest) | ₹10,000 | ₹13,000 | 30.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹13,382.25 | 33.8% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
